Aortic & peripheral vascular disease

Two-Year Outcomes of the Prospective THRILLER Registry on Popliteal and Infrapopliteal Endovascular Interventions for Chronic Limb-threatening Ischemia (CLTI)

JACC Cardiovasc IntervPublished prospective multicenter registry

Authors' conclusion

Endovascular revascularization for popliteal and infrapopliteal disease in patients with CLTI is safe and effective in preventing limb loss and mortality at 2 years, although patients with Rutherford 6 limbs face significantly worse outcomes, particularly in the first 3 months.

Study context

Population
Patients with chronic limb-threatening ischemia (CLTI) undergoing popliteal or infrapopliteal endovascular revascularizationpatients, 1,119 interventions in 1,060 limbs, treating 551 popliteal, 1,352 tibial, and 239 pedal lesions, 78.4% (831/1,060) of limbs Rutherford 5, 8.1% (86/1,060) Rutherford 6, 41.3% (382/926) WIfI stage 4
Participants
938 patients
Exposure
Rutherford 6 vs Rutherford 5 limbs
  • Rutherford 6n = 86
  • Rutherford 5n = 831reference
Outcome
Limb salvage and amputation-free survival (AFS)
Follow-up
24 months
Methodological detailsconsecutive patients, seven Dutch hospitals
  • Consecutive patients
  • Seven Dutch hospitals

Main finding

As reported in the abstract

Hazard ratio (95% CI)P value
Rutherford 6 vs Rutherford 5limb salvage; significantly worse with Rutherford 6
3.07 (1.89–4.99), event not clearly stated
P < 0.001
Rutherford 6 vs Rutherford 5AFS; significantly worse with Rutherford 6
2.07 (1.50–2.86), event not clearly stated
P < 0.001
Rutherford 6 vs Rutherford 4AFS, first 3 months
14.13 (4.94–40.38), event not clearly stated
P < 0.001

Observational data: associations, not effects.

Further findings

Technical success

Technical success
92.3% (1,033/1,119)

Follow-up

Median follow-up
43.6 months (Q1-Q3: 35.5-52.7 months)

Original publication

Two-Year Outcomes of the Prospective THRILLER Registry on Popliteal and Infrapopliteal Endovascular Interventions for CLTI. JACC Cardiovasc Interv. Published 26 October 2026. doi:10.1016/j.jcin.2026.07.044

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.